Docking analyses on human muscarinic receptors: Unveiling the subtypes peculiarities in agonists binding

Bioorganic & Medicinal Chemistry
2008.0

Abstract

The study presents a docking analysis for the interaction capabilities of some muscarinic receptors (i.e., M(1), M(2), and M(5)) whose full-length models were previously generated by us. In detail, the docking simulations involved a dataset of 30 agonists, taken from the literature, including a first series of oxathiolane/dioxolane congeners and a second subset of more heterogeneous ligands. The obtained results unveil that it is possible to discriminate among the binding modes of considered muscarinic receptors, developing specific interaction patterns which are significantly different for the arrangement of both polar and hydrophobic interactions. Thus, the M(1) subtype possesses the widest binding site, while the M(2) receptor is characterized by a large but asymmetric region that accommodates the ligand's ammonium head and finally the M(5) binding site is quite similar to that of M(2) subtype being univocally characterized by a second aspartate residue which interacts with the ammonium head. The significant correlations between docking scores and affinity values afford an encouraging validation for the reported binding modes and confirm the key role of molecular flexibility in the ligand recognition of muscarinic receptors.

Knowledge Graph

Similar Paper

Docking analyses on human muscarinic receptors: Unveiling the subtypes peculiarities in agonists binding
Bioorganic & Medicinal Chemistry 2008.0
Conjugation of Short Peptides to Dibenzodiazepinone-Type Muscarinic Acetylcholine Receptor Ligands Determines M<sub>2</sub>R Selectivity
Journal of Medicinal Chemistry 2019.0
Ligand Selectivity for the Acetylcholine Binding Site of the Rat α4β2 and α3β4 Nicotinic Subtypes Investigated by Molecular Docking
Journal of Medicinal Chemistry 2005.0
Synthesis and In vitro binding affinities of 1-azabicyclic compounds as muscarinic ligands
Bioorganic &amp; Medicinal Chemistry Letters 2001.0
Dualsteric Muscarinic Antagonists–Orthosteric Binding Pose Controls Allosteric Subtype Selectivity
Journal of Medicinal Chemistry 2014.0
Radiolabeled Dibenzodiazepinone-Type Antagonists Give Evidence of Dualsteric Binding at the M<sub>2</sub> Muscarinic Acetylcholine Receptor
Journal of Medicinal Chemistry 2017.0
Muscarinic agonist, (±)-quinuclidin-3-yl-(4-fluorophenethyl)(phenyl)carbamate: High affinity, but low subtype selectivity for human M1 – M5 muscarinic acetylcholine receptors
Bioorganic &amp; Medicinal Chemistry Letters 2019.0
Synthesis and muscarinic receptor activity of ester derivatives of 2-substituted 2-azabicyclo[2.2.1]heptan-5-ol and -6-ol
Journal of Medicinal Chemistry 1992.0
Homology Modeling of Metabotropic Glutamate Receptors. (mGluRs) Structural Motifs Affecting Binding Modes and Pharmacological Profile of mGluR1 Agonists and Competitive Antagonists
Journal of Medicinal Chemistry 1996.0
Synthesis and Biological Characterization of 1,4,5,6-Tetrahydropyrimidine and 2-Amino-3,4,5,6-tetrahydropyridine Derivatives as Selective m1 Agonists
Journal of Medicinal Chemistry 1997.0